
Opinion|Podcasts|June 3, 2024
Generational Trends and Innovations in Retinal Disease Care
Listen
0:00 / 0:00
Key Takeaways
- The Ang/Tie pathway is a promising target for novel cancer therapies, highlighting its potential in treatment strategies.
- Re-evaluation of steroid use in oncology may impact patient management and treatment outcomes.
A panel of ophthalmologists discuss how retinal disease management has evolved in the past decade and continues to change with advancements in diagnostics and therapies.
Advertisement
1:00 Evolving trends
5:50 Key Advances
8:20 Targeting Ang/Tie pathway
13:12 Role of steroids
15:00 Biosimilars
18:44 Therapies in the pipeline
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
Brensocatib Patient Selection Evolves 1 Year After FDA Approval
2
CKM Syndrome, Artery Damage Prevalence Higher in Young Adults than Previously Believed
3
The HCPFive: Top News for Healthcare Providers from the Week of 08/16
4
ABTECT Maintenance Data Show Durable Remission in UC, With Remo Panaccione, MD
5







































































